FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada
April 11th, 2019
Exclusive, News, Top News
Cannabis investors have been focused largely on the recreational market with the legalization of adult-use cannabis last year, but a growing body of research suggests that medical cannabis remains a compelling long-term opportunity. The biggest question mark has been surrounding insurance coverage, which could prove to be a game-changer by making medical cannabis a lot more affordable to a much wider patient population.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FFT: 0K9) has recognized these trends and recently hired an insurance expert to plan out its approach ahead of its sales license that’s expected later this year.
Canada’s Health Insurance Market
Canada has a public healthcare system that provides preventative care and medical treatment from primary care physicians along with access to hospitals and other medical services. While some prescription medications are available through public programs, most Canadians pay out of pocket or use private health insurance. Roughly two-thirds of Canadians have some kind of private health insurance for this reason.
Most private insurance companies don’t cover medical cannabis outright because it doesn’t have a Drug Identification Number, or DIN, which means that it’s not a fully-approved medicine. While they don’t provide outright coverage, many insurance companies do offer Health Care Spending Accounts, where money is set aside to cover expenses. The downside is that only a small minority of the population maintains these types of accounts.
The good news is that these trends are starting to change. For example, Sun Life Assurance Co., a major Canadian health insurance company, recently announced that it would add medical cannabis to its group benefits plan last year. The yearly maximums for the coverage will range from $1,500 to $6,000 with eligible symptoms that include cancer, multiple sclerosis, rheumatoid arthritis, HIV/AIDS, and palliative care.
FSD Pharma Targets Insurance Markets
FSD Pharma recently signed a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track record in personal injury law where he has been assisting people with using medical cannabis to cope with pain. Under the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage, and no fault benefits across Canada.
“We are very excited to engage Mr. Romano in advance of our anticipated sales license,” said FSD Pharma Executive Chairman and Interim CEO in the press release announcing the deal. “This is a very timely and important agreement for FSD Pharma to maximize the opportunities in the Canadian market for our products and fits well with our strategy of establishing the company as a leader in medical cannabis.”
As the company moves closer to obtaining a sales license, health insurance expertise could become invaluable in creating potential end markets. The company’s massive ~3.4 million sq. ft. former Kraft Foods facility is well positioned to not only enable significant cannabis cultivation levels, but also house processing, manufacturing, extraction, and research and development facilities to build incremental shareholder value.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FFT: 0K9) recently hired a health insurance expert to help it navigate insurance coverage issues for medical cannabis patients. As Canada’s policies continue to evolve, these insurance coverages could play a big role in making medical cannabis more affordable to patients in need, and accelerating the growth of the industry as it works to address underserved medical needs.
For more information, visit the company’s website at www.fsdpharma.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.